Information Journal Paper
APA:
Copy. (2017). Systematic Review and Meta-analysis: Adalimumab Monotherapy Versus Combination Therapy with Immunomodulators for Induction and Maintenance of Remission and Response in Patients with Crohn's Disease. INFLAMMATORY BOWEL DISEASES, 23(-), 1316-1327. SID. https://sid.ir/paper/736301/en
Vancouver:
Copy. Systematic Review and Meta-analysis: Adalimumab Monotherapy Versus Combination Therapy with Immunomodulators for Induction and Maintenance of Remission and Response in Patients with Crohn's Disease. INFLAMMATORY BOWEL DISEASES[Internet]. 2017;23(-):1316-1327. Available from: https://sid.ir/paper/736301/en
IEEE:
Copy, “Systematic Review and Meta-analysis: Adalimumab Monotherapy Versus Combination Therapy with Immunomodulators for Induction and Maintenance of Remission and Response in Patients with Crohn's Disease,” INFLAMMATORY BOWEL DISEASES, vol. 23, no. -, pp. 1316–1327, 2017, [Online]. Available: https://sid.ir/paper/736301/en